Investors Snatch TCRX 6.7% Lower Than Its Secondary Stock Offering

Looking back to 2 days ago, TScan Therapeutics Inc (TCRX) priced a 2,472,581 share secondary stock offering at $7.13 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..